Search clinical trials for: Phase Ib: Peposertib

Total 1328 results

Immatics Biotechnologies GmbH
Bristol-Myers Squibb

Recruiting

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors

Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer

Germany
Boryung Pharmaceutical Co., Ltd

Active, not recruiting

BR101801 in Adult Patients With Advanced Hematologic Malignancies( Phase I)

Follicular Lymphoma | B Cell Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Small Lymphocytic Leukemia

Korea, Republic of, United States
Immatics Biotechnologies GmbH

Recruiting

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer

Germany
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

A Study of HS-20089 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
CStone Pharmaceuticals
Blueprint Medicines Corporation

Completed

A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Recruiting

A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Acute Gout

China
Jason J. Luke, MD
Array BioPharma

Active, not recruiting

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma

United States
Butantan Institute
Butantan Foundation

Active, not recruiting

Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

Influenza, Human

Brazil
National University Hospital, Singapore
Merck Sharp & Dohme LLC; Adagene Inc

Recruiting

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer (ComPACT)

Triple Negative Breast Cancer | Advanced Solid Tumor

Singapore
Centre Hospitalier Universitaire, Amiens
Merck Serono International SA

Completed

May Metformin be Used in Renal Failure?

Renal Disorder Associated With Type II Diabetes Mellitus

France
Haukeland University Hospital
University of Oslo; Oslo University Hospital; University Hospital of North Norway and other collaborators

Recruiting

Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) (BORTEM-17)

Glioblastoma

Norway
Case Comprehensive Cancer Center

Withdrawn

Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer

Metastatic Colorectal Cancer
Fujian Cancer Hospital

Not yet recruiting

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Nasopharyngeal Carcinoma
Minghui Pharmaceutical Pty Ltd

Not yet recruiting

MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis

Rheumatoid Arthritis | Atopic Dermatitis
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer

Locally Advanced Rectal Cancer

United States, Spain
Fujian Cancer Hospital

Unknown

Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

Nasopharyngeal Carcinoma

China
M.D. Anderson Cancer Center
Agenus Inc.

Recruiting

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

Oropharyngeal Cancer | HPV

United States
Can-Fite BioPharma

Completed

Trial of CF101 to Treat Patients With Dry Eye Disease

Keratoconjunctivitis Sicca

Israel
Can-Fite BioPharma

Withdrawn

A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

Israel
Can-Fite BioPharma

Completed

Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

United States, Israel, Bulgaria, Romania, Serbia
Telix International Pty Ltd
Merck KGaA, Darmstadt, Germany

Recruiting

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

Advanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell Carcinoma

Australia
Can-Fite BioPharma

Completed

Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure

Ocular Hypertension | Glaucoma

Israel, Bulgaria
Can-Fite BioPharma

Completed

Trial of CF101 to Treat Patients With Psoriasis

Plaque Psoriasis

Israel, United States, Bulgaria, Romania
Pfizer

Withdrawn

Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease

Inflammatory Bowel Disease

United States
Can-Fite BioPharma

Withdrawn

Safety &Efficacy of CF101 to Subjects With Uveitis

Uveitis, Posterior | Uveitis, Intermediate

Israel
Can-Fite BioPharma

Completed

A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1

Chronic Hepatitis C

Israel
H. Lee Moffitt Cancer Center and Research Institute
Patient-Centered Outcomes Research Institute

Completed

Navigator Guided e-Psychoeducational Intervention

Prostate Cancer

United States
1ST Biotherapeutics, Inc.
Merck Sharp & Dohme LLC

Recruiting

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

Advanced Solid Tumor

United States
Can-Fite BioPharma

Completed

Safety and Efficacy Study of CF101 to Treat Psoriasis

Plaque Psoriasis

Israel
Wake Forest University Health Sciences
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Healthy Living Partnership to Prevent Diabetes (HELP PD)

Obesity | Prediabetes

United States
Can-Fite BioPharma

Completed

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

Non-alcoholic Steatohepatitis (NASH)

Israel
Thuasne

Recruiting

Contribution of an Off-the-shelf Carbon Ankle Foot Orthosis (AFO) in the Management of Walking Functional Impairment (DEFISTEP)

Neuropathy (Disorder)

France
Children's Hospital Medical Center, Cincinnati
Uganda Heart Institute

Completed

Train the Trainer Curriculum to Scale up AI Supported Echo for RHD Screening in a Public Health System (ADD-RHD 2B)

Rheumatic Heart Disease

Uganda
University of British Columbia
Canadian Foundation for Dental Hygiene Research and Education; British Columbia... and other collaborators

Completed

Comparing the Inter-dental Brush to Dental Floss

Gingivitis

Canada
University of Edinburgh
NHS Lothian; NHS Greater Glasgow and Clyde

Unknown

High-Sensitivity Cardiac Troponin On Presentation to Rule Out Myocardial Infarction (HiSTORIC)

Myocardial Infarction | Acute Coronary Syndrome
Fundació Institut de Recerca de l'Hospital de la...

Completed

Effect of Tomato Soffritto Intake on Biomarkers of Cardiovascular Disease in an Overweight and Obesity (FRITOCARD)

Dietary Exposure

Spain
Kocaeli University

Recruiting

Consequences of Admission to the Delivery Room in the Early and Late Phases

Pain | Satisfaction | Fear of Childbirth | Neonatal | Maternal Distress (During Labor)

Turkey
SVSE 2000 Ltd.

Unknown

Evaluation of Mechanical Stapler for Aortic Anastomoses

Aortic Aneurysm, Abdominal | Leriche Syndrome

Germany
Duke University
National Institute of Mental Health (NIMH)

Completed

CAMPUS - Feasibility Sub-Study (CAMPUS-Feas)

Suicide

United States
Bharat Biotech International Limited
Indian Council of Medical Research

Completed

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers (BBV152)

COVID-19 | SARS-CoV-2 Infection

India
Janssen Research & Development, LLC

Completed

A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Relapsed or Refractory Hodgkin Lymphoma

France, Germany
Janssen Research & Development, LLC

Terminated

A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

France, United Kingdom, Spain, Belgium, Netherlands, Germany, Denmark
Shenzhen Precision Health Food Technology Co. Ltd...

Completed

The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

Diabetes | Sugar; Blood, High

China
Jacqueline Isaura Alvarez Leite
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional...

Completed

Effects Gluten Intake on Body Composition, Energy Expenditure and Adipokine Profile in Non-celiac Women With Obesity

Obesity
University of British Columbia

Completed

Home-Based Walking Study in Older Adults With Type 2 Diabetes

Diabetes | Type 2 Diabetes | Orthostatic Hypotension | Cardiovascular

Canada
KK Women's and Children's Hospital
National University Hospital, Singapore; Singapore General Hospital

Recruiting

Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia

Lymphoblastic Leukemia, Acute, Childhood | Lymphoblastic Leukemia | Lymphoblastic Leukemia, Acute Adult | Lymphoblastic Leukemia in Children | CAR

Singapore
European Institute of Oncology

Recruiting

Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer

Breast Cancer

Italy
University of Chicago

Recruiting

Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients

Multiple Myeloma

United States
Brigham and Women's Hospital

Withdrawn

Lung Irradiation for COVID-19 Pneumonia

SARS-CoV 2

United States

Search clinical trials for: Phase Ib: Peposertib

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations